HRT - who is it for? #hormonehealth #shorts #menopause
14 Jul 2023 · 1 min

0:42
In this short video, the speaker explains that women who experience menopause before age 40 (premature menopause) or between ages 40 and 45 (early menopause) are a key group that may especially benefit from menopausal hormone therapy (MHT). The early loss of estrogen and other ovarian hormones in these women is linked to higher risks of heart disease, other cardiovascular problems, cognitive decline, osteoporosis, and additional adverse health outcomes. Consequently, MHT can be an important therapeutic option to mitigate these risks for women with early or premature menopause.










